Research & Development
Signifier Medical Technologies concludes oversubscribed Series B funding round
17 June 2019 - Medical technology company Signifier Medical Technologies revealed on Friday the completion of an oversubscribed Series B funding round led by The Pritzker Organization and includes par...
Ampio provides regulatory and clinical update of the AP-013 trial for OA
17 June 2019 - Biopharmaceutical company Ampio Pharmaceuticals, Inc (NYSE MKT:AMPE) reported on Friday the receipt of US FDA approval of the special protocol assessment (SPA) of a clinical protocol ti...
22nd Century Group promotes Michael J. Zercher to COO
17 June 2019 - Plant biotechnology company 22nd Century Group Inc (NYSE American:XXII) reported on Friday the election of Michael J. Zercher as its chief operating officer.In his new position, Zercher...
Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma
14 June 2019 - - The US Food and Drug Administration has approved its PD-L1 IHC 22C3 pharmDx assay for expanded use, US-based Agilent Technologies Inc. (NYSE: A) said.
The assay is now appr...
New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV's DPX-Survivac in Combination with US Merck's Keytruda in Patients with DLBCL
14 June 2019 - - Canadian immuno-oncology corporation IMV Inc. (NASDAQ: IMV) (TSX: IMV) has released updated data from the ongoing investigator-sponsored SPiReL Phase 2 clinical trial assessing IMV�...
FDA Grants Priority Review to Genentech's Rituxan in Children with Two Rare Blood Vessel Disorders
14 June 2019 - - The US Food and Drug Administration has accepted US-based Genentech's supplemental Biologics License Application and granted Priority Review for the use of Rituxan (rituxima...